A5081896560- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Immunodeficiency and Autoimmune Disorders
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
- SARS-CoV-2 and COVID-19 Research
- Reproductive System and Pregnancy
- Glycosylation and Glycoproteins Research
- COVID-19 Clinical Research Studies
- Forensic and Genetic Research
- Autoimmune and Inflammatory Disorders Research
- Ectopic Pregnancy Diagnosis and Management
- Diabetes and associated disorders
- Renal Transplantation Outcomes and Treatments
- Molecular Biology Techniques and Applications
- Cytomegalovirus and herpesvirus research
- Genomic variations and chromosomal abnormalities
- Atherosclerosis and Cardiovascular Diseases
- Cancer Genomics and Diagnostics
- Long-Term Effects of COVID-19
- Galectins and Cancer Biology
- Cell Adhesion Molecules Research
- Pregnancy and Medication Impact
Evangelismos Hospital
2009-2025
Areté Associates (United States)
2023
ABSTRACT The HLA‐B*39:01:01:31 allele differs from HLA‐B*39:01:01:03 by a single nucleotide substitution in intron 2.
ABSTRACT The HLA‐B*18:05:01:03 allele differs from HLA‐B*18:05:01:02 by a single‐nucleotide substitution in Intron 5.
In the realm of DNA testing with legal implications, reliability and precision genetic markers play a pivotal role in confirming or negating paternity claims. This study aimed to assess potential utility human leukocyte antigen (HLA) gene polymorphism through massively parallel sequencing (MPS) technology as robust forensic for parentage involving deficiencies. It sought redefine significance HLA genes this context. Data on autosomal short tandem repeat (aSTR) mutational events across 18...
HLA‐C * 01:02:01:70 differs from the 01:02:01:01 allele by one nucleotide substitution in intron 4.
HLA‐C * 04:01:01:174 differs from the 04:01:01:06 allele by one nucleotide substitution in intron 5.
The HLA-DQB1*03:01:01:64 allele differs from HLA-DQB1*03:01:01:03 by a single nucleotide substitution in intron 2.
The HLA-DQB1*06:02:01:40 allele differs from HLA-DQB1*06:02:01:01 by a single nucleotide substitution in intron 2.
ABSTRACT HLA‐DQB1*03:01:01:65 and ‐ DQB1*05:02:01:18 were detected in a Greek individual.
ABSTRACT The HLA‐A*01:01:01:121 allele differs from HLA‐A*01:01:01:01 by a single nucleotide substitution in intron 4.
HLA‐A*01:01:01:112 differs from the HLA‐A*01:01:01:01 allele by one nucleotide substitution in 5'UTR.
HLA‐B*41:02:01:11 and ‐C*08:266 were detected in a solid organ recipient during the HLA typing process.
HLA‐B*47:01:01:07 differs from the HLA‐B*47:01:01:03 allele by one nucleotide deletion in 3′UTR.
HLA‐C*17:01:01:29 differs from the HLA‐C*17:01:01:05 allele by one nucleotide substitution in 3′UTR.
Characterisation of the novel HLA‐C*07:01:01:141 allele in a 23‐year‐old Greek bone marrow donor.
The HLA‐DRB1*03:218N allele differs from HLA‐DRB1*03:174N by a single nucleotide substitution in exon 2.
ABSTRACT The HLA‐DQB1*03:01:01:69 allele differs from HLA‐DQB1*03:01:01:03 by a single nucleotide substitution in intron 2.
ABSTRACT The HLA‐DQB1*05:02:01:19 allele differs from HLA‐DQB1*05:02:01:01 by a single nucleotide substitution in intron 3.